Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patientsLaura S. Mertens, Bas W.G. van Rhijn, Joost L. Boormans et al.|Urologic Oncology Seminars and Original Investigations|2021Cited by 39
T1 Substaging of Nonmuscle Invasive Bladder Cancer is Associated with bacillus Calmette-Guérin Failure and Improves Patient Stratification at DiagnosisFlorus C. de Jong, Tahlita C.M. Zuiverloon, Robert F. Hoedemaeker et al.|The Journal of Urology|2020Cited by 27
Definitions of BCG-failure (EAU) vs BCG-unresponsive (FDA) in high-risk non-muscle invasive bladder cancer: A comparison of patient outcomeFlorus C. de Jong, Tahlita C.M. Zuiverloon, Robert F. Hoedemaeker et al.|European Urology Open Science|2020Cited by 2